An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, tolerability and safety of
JNJ-38518168 compared with placebo in adult participants with active rheumatoid arthritis
(long time systemic disease of the joints, marked by inflammatory changes in the synovial
membranes and bones) despite methotrexate (MTX) therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.